Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Triad Medical

This article was originally published in The Gray Sheet

Executive Summary

Triad Medical: Initial public offering of 4 mil. shares at $10-12 each is anticipated by the firm, according to a Sept. 11 filing with the Securities and Exchange Commission. The medical product contract sales and distribution concern plans to use anticipated proceeds of $37 mil. (assuming an IPO price of $11) to expand its product representation through the acquisition of local and regional contract sales and distribution companies, and for debt repayment, the firm states. Concurrently with the offering, Laguna Hills, California-based Triad will acquire 11 firms: Triad Holdings, Healthcare Technology Delivery, Sun Medical, Custom Medical Specialties, Kentec Medical, Products For Surgery, MegaTech Medical, Omni Medical, New England Medical Specialties, Professional Equipment and Wilson Medical Specialties, with pro forma 1996 revenues of $127.9 mil. Montgomery Securities, Smith Barney and Wedbush Morgan Securities are underwriters for the offering...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel